Veracyte, Inc. (VCYT)

20.13 +0.56 (+2.86%) 收市：04:00PM EDT

Veracyte, Inc.

6000 Shoreline Court
Suite 300
South San Francisco, CA 94080
United States
650 243 6300
https://www.veracyte.com

版塊: Healthcare
行業: Diagnostics & Research
全職員工: 815

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. Marc A. Stapley	CEO & Director	1.55M	無	1970
Ms. Rebecca Chambers	Executive VP & CFO	901.49k	無	1978
Dr. Phillip G. Febbo M.D.	Chief Scientific & Medical Officer	657.74k	無	1966
Ms. Annie McGuire	Executive VP, General Counsel & Chief People Officer	791.72k	無	1981
Dr. John Leite Ph.D.	Chief Commercial Officer for CLIA Business	1.53M	無	1972
Mr. Jonathan Wygant	VP & Chief Accounting Officer	無	無	1971
Mr. Steven French	Senior VP & Chief Information Officer	無	無	無
Ms. Karen Possemato	Senior Vice President of Corporate Marketing, Communications & Commercial Operations	無	無	無
Mr. Robert Brainin	Executive VP & Chief Business Officer	無	無	1971
Ms. Corinne Danan	Senior Vice President	無	無	無

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; Percepta Nasal Swab Test for lung cancer diagnosis; and Envisia Genomic Classifier for diagnosing interstitial lung disease, including idiopathic pulmonary fibrosis. It is also developing Envisia Classifier, the nCounter analysis system; and LymphMark for lymphoma subtyping test. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.

公司管治

截至 2024年4月29日 止，Veracyte, Inc. 的 ISS 管治質素評分為 4。 Pillar 分數正在審核中：5；董事會：2；股東權利：4；現金賠償：7。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。